首页|丝裂原活化蛋白激酶15纳米抗体的制备及其在B16-F10黑素瘤细胞生长过程中的抑制作用

丝裂原活化蛋白激酶15纳米抗体的制备及其在B16-F10黑素瘤细胞生长过程中的抑制作用

扫码查看
丝裂原活化蛋白激酶15(mitogen-activated protein kinase 15,MAPK15),又称ERK7 或ERK8,是MAPK 家族的非典型新成员。MAPK15 不同程度地促进不同肿瘤细胞的增殖、迁移、自噬等细胞活动。本研究以MAPK15 为靶点,筛选特异性的MAPK15 纳米抗体,评估其是否能够作为免疫组织化学和Western 印迹中的一抗用于其抗原表达的检测,并探究该纳米抗体在B16-F10 黑色素瘤细胞中的作用。通过噬菌体展示技术从B16-F10 黑色素瘤细胞纳米抗体文库中进行筛选,得到1 株MAPK15 特异性纳米抗体,命名为MAPK15-VHH;将该菌株构建原核表达载体,进行优化诱导表达条件时发现,0。6 nmol/L IPTG,15℃,100 r/min条件下该纳米抗体的上清表达量最高。通过竞争ELISA 法检测MAPK15-VHH 的亲和力,结果显示,该抗体KD 值为0。9829。通过Western 印迹和免疫组织化学检测脑组织中MAPK15 在蛋白质水平的表达量及分布情况,结果表明,MAPK15-VHH 可与组织中的MAPK15 结合,用于检测MAPK15 蛋白的表达情况。在B16-F10 黑色素瘤细胞中过表达MAPK15 后向其中添加MAPK15-VHH,通过CCK8、Western 印迹以及实时荧光定量PCR检测其对该细胞增殖和自噬的影响,结果显示,该MAPK15-VHH 能作为MAPK15 的拮抗剂,抑制B16-F10 细胞的增殖和自噬,从而抑制黑素瘤细胞的生长。综上所述,本研究成功得到一株亲和力较强的MAPK15 纳米抗体,可用于Western 印迹及免疫组织化学以检测MAPK15 在蛋白质水平的表达及分布;此外,该MAPK15 纳米抗体可以作为MAPK15 拮抗剂,有效地抑制B16-F10细胞的增殖和自噬进程,为临床检测试剂和治疗药物的开发提供理论基础。
Preparation of MAPK15 Nanobody and Its Inhibitory Effect on the Growth of B16-F10 Melanoma Cells
Mitogen-activated protein kinase 15(MAPK15),also known as ERK7 or ERK8,is an atypi-cal new member of the MAPK family.MAPK15 promotes cancer cell proliferation,migration,autophagy and other cellular activities in different tumors at different degrees.In this research,we screened for spe-cific MAPK15 nanobody,then evaluated whether it could be used as primary antibodies in Western blot-ting and immunohistochemistry for the detection of its antigen expression,and investigated its role in B16-F10 melanoma cells.The results showed that a strain of MAPK15-specific nanobody was screened from B16-F10 melanoma cell nanobody library through phage display technology,which we named MAPK15-VHH.The strain was constructed into a prokaryotic expression vector,and we found that the nanobody expression level in the supernatant was the highest under the conditions of 0.6 nmol/L IPTG,15℃,and 100 r/min basing on optimizing the induction expression conditions.The affinity of MAPK15-VHH was detected by competitive ELISA,and the results showed that the KD value of MAPK15-VHH was 0.9829.MAPK15-VHH was used as the primary antibody in Western blotting and immunohistochemistry assays to detect the expression and distribution of MAPK15 in brain tissues by binding to MAPK15.After overex-pressing MAPK15 in B16-F10 melanoma cells,MAPK15-VHH was added to the medium,and its effect on cell proliferation and autophagy was detected by CCK8,Western blotting and quantitative real-time PCR.The results showed that the MAPK15-VHH could act as an antagonist of MAPK15 to inhibit the proliferation and autophagy of B16-F10 cells,thereby inhibiting the growth of B16-F10 melanoma cells.In summary,the MAPK15 nanobody obtained in this research had strong affinity,which could be used as a primary antibody in Western blotting and immunohistochemistry assays to detect the expression and dis-tribution of MAPK15.In addition,the MAPK15 nanobody could serve as a MAPK15 antagonist to effi-ciently inhibit the proliferation and autophagy of B16-F10 cells,which provided a theoretical basis for the development of clinical detection reagents and therapeutic drugs.

mitogen-activated protein kinase 15(MAPK15)nanobodymelanoma cellproliferationautophagy

贾琼、金聪俐、胡世雄、秦蓉芬、赵立峰、范瑞文

展开 >

山西农业大学动物医学学院,山西,晋中 030801

天津市北辰区农业发展服务中心,天津 300400

丝裂原活化蛋白激酶15 纳米抗体 黑色素瘤细胞 增殖 自噬

山西省研究生创新项目(2021)

2021Y318

2024

中国生物化学与分子生物学报
中国生物化学与分子生物学会 北京大学

中国生物化学与分子生物学报

CSTPCD北大核心
影响因子:0.617
ISSN:1007-7626
年,卷(期):2024.40(1)
  • 26